# EFFICACY of INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION on the POSTOPERATIVE BLOOD LOSS in PATIENTS UNDERGOING RARP for the TREATMENT of PROSTATE CANCER

> **NCT06822036** · NA · RECRUITING · sponsor: **St. Antonius Hospital Gronau** · enrollment: 362 (estimated)

## Conditions studied

- Prostate Cancer (Adenocarcinoma)
- Blood Loss, Postoperative
- Erectile Function

## Interventions

- **PROCEDURE:** Arm A - Application of 5g of ARISTA™ AH

## Key facts

- **NCT ID:** NCT06822036
- **Lead sponsor:** St. Antonius Hospital Gronau
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-16
- **Primary completion:** 2026-01-30
- **Final completion:** 2027-01-30
- **Target enrollment:** 362 (ESTIMATED)
- **Last updated:** 2025-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06822036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06822036, "EFFICACY of INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION on the POSTOPERATIVE BLOOD LOSS in PATIENTS UNDERGOING RARP for the TREATMENT of PROSTATE CANCER". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT06822036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*